List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1113 studies with search of: Mexico
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Enrolling by invitation A Open Label Study of a Flexible Dose of Brivaracetam in Subjects 16 Years or Older Suffering From Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam (ucb 34714)
2 Completed Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
3 Completed Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etex;   Drug: Warfarin
4 Recruiting (ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: ambrisentan or sugar pill
5 Completed
Has Results
Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastases
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
6 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
7 Completed A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: GLP-1;   Drug: Placebo
8 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
9 Recruiting A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)
Condition: Atrial Fibrillation
Interventions: Drug: Vernakalant;   Drug: Placebo
10 Completed A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab Pegol
11 Active, not recruiting A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: MVA-BN® (IMVAMUNE);   Biological: IMVAMUNE
12 Recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
13 Recruiting Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
14 Active, not recruiting Phase IIIB Switching From Intravenous to Subcutaneous Study
Condition: Arthritis, Rheumatoid
Intervention: Drug: Abatacept
15 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
16 Completed Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Tamsulosin;   Drug: AVODART
17 Recruiting Phase 3 Study to Evaluate Efficacy and Safety of Oxcarbazepine Extended-Release in Subjects With Refractory Partial Seizures Due to Epilepsy When Used With up to 3 Other Antiepileptic Drugs.
Condition: Epilepsy
Interventions: Drug: Placebo;   Drug: Oxcarbazepine Extended Release
18 Active, not recruiting Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: glimepiride;   Drug: metformin;   Drug: sitagliptin;   Biological: albiglutide
19 Completed Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes
Intervention: Drug: Insulin sensitizer
20 Terminated Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options